Home » Cipher Completes Sale of Pharmaceutical Research Services Business
Cipher Completes Sale of Pharmaceutical Research Services Business
Cipher Pharmaceuticals has completed the previously announced sale of its pharmaceutical research services business, Pharma Medica Research, to a group led by the current management team of Pharma Medica. Consideration consisted of a cash payment of $14 million, a deferred payment of $4 million (payable over five years), and payment of a special dividend of $1.1 million from Pharma Medica to Cipher. Pharma Medica has also retained all its existing debt.
Yahoo News (http://biz.yahoo.com/cnw/050302/cipher_completes_sale_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct